After-Hours, ResMed Inc.

ResMed stock last trades at USD 219.41 on September 28, 2026

Published on 09/28/2026 at 18:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ResMed last traded at USD 219.41 on September 28, 2026, down 1.17 percent. The company has issued fiscal 2027 guidance for core constant-currency revenue growth of 5 percent to 7 percent.

Unbranded CPAP-Gerät mit Atemmaske und Schlauch auf einem Nachttisch im Schlafzimmer
ResMed Inc. (ISIN US7611521078): generisches CPAP-Atemgerät mit Maske und Schlauch steht auf einem Nachttisch, Illustration mit AI erstellt.

ResMed Inc. (NYSE: RMD) was last traded at USD 219.41 on September 28, 2026, at 16:19:25 UTC, down 1.17 percent from the previous close of USD 222.00.

Trading session

The quote was recorded during the regular session on the New York Stock Exchange. The stock data is presented separately from ResMed’s company announcements.

Fiscal 2027 outlook

In its fiscal fourth-quarter 2026 earnings call on August 6, 2026, ResMed provided fiscal 2027 guidance for core constant-currency revenue growth of 5 percent to 7 percent and core earnings-per-share growth of 12 percent to 14 percent. The guidance uses a non-GAAP core EPS basis and includes the expected impact of the Astral field safety action, according to the earnings transcript.

At the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, management reiterated the fiscal 2027 outlook and said the Astral field safety notice represents an approximately USD 75 million revenue headwind. ResMed also said it plans to sunset the Astral platform after 15 years and will make no new Astral sales in fiscal 2027, according to the conference transcript published by Investing.com.

Disclaimer...

en | boerse | 70193961 |